Notification No 56/2015-2020 Dated. 24thFebruary, 2022
Issued By. DGFT
Subject : Amendment in Export Policy of Remdesivir Injection and API, Amphotericin-B Injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) - regarding
*****
The Central Government has made amendment in the export policy of Remdesivir Injection and API, Amphotericin-B Injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) as below :-
|
Sl No |
ITC HS Code |
Description |
Present Policy |
Revised Policy |
|
207 AA |
Ex 293499Ex 300490 |
Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) |
Restricted |
Free |
|
207 AB |
Ex 30049029Ex 30049099 |
Amphotericin - B Injections | ||
|
207 AE |
Ex 2942Ex 3001 |
Enoxaparin (Formulation and API) | ||
|
207 AF |
Ex 3002 |
Intra-Venous Immunoglobulin (IVIG) (Formulation and API) |
Analysis
|
Sl No |
Particulars |
Remarks |
|
01 |
Effect of the Notification |
The export policy of Injection Remdesivir and Remdesivir API, Amphotericin - B injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) falling under HS code as mentioned above or falling under any other HS code has been made 'Free' with immediate effect. |